Pasithea Therapeutics Corp.
KTTA | NASDAQ
$0.51
-$0.01 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.51
$0 (+0.16%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 15.06K | n/a |
Cost of Revenue | n/a | n/a | n/a | 5.09K | 17.28K | n/a |
Gross Profit | n/a | n/a | n/a | -5.09K | -2.21K | n/a |
Operating Income | -20.86M | -14.25M | -15.98M | -12.59M | -4.51M | -61.48K |
Interest Income | 327.19K | 423.18K | n/a | n/a | n/a | n/a |
Pretax Income | -20.43M | -13.9M | -15.51M | -11.73M | -2.17M | -61.48K |
Net Income | -20.43M | -13.9M | -15.96M | -13.94M | -2.17M | -61.48K |
Selling & General & Admin | 12.88M | 7.05M | 7.88M | 9.92M | 4.51M | n/a |
Research & Development | 7.98M | 7.2M | 8.1M | 2.67M | n/a | n/a |
Other Expenses | n/a | n/a | 7.88M | n/a | 4.51M | 61.48K |
Operating Expenses | 20.86M | 14.25M | 15.98M | 12.58M | 4.51M | 61.48K |
Interest Expense | n/a | n/a | n/a | 102 | 508 | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.86M | 14.25M | 15.98M | 12.59M | 4.52M | 61.48K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7.03M | 1.1M | 1.23M | 1.26M | 1.15M | 688.92K |
Shares Outstanding (Diluted) | 7.03M | 1.1M | 1.23M | 1.26M | 1.15M | 688.92K |
EPS (Basic) | -2.91 | -12.69 | -13.01 | -10.34 | -1.89 | -0.06 |
EPS (Diluted) | -2.91 | -12.69 | -13.01 | -10.34 | -1.89 | -0.06 |
EBITDA | -20.19M | -13.6M | -15.33M | -11.72M | -4.51M | n/a |
EBIT | -20.86M | -14.25M | -15.98M | -11.73M | -4.51M | -61.48K |
Depreciation & Amortization | 662.59K | 649.03K | 648.45K | 5.09K | 1.38K | 61.48K |
Add to Watchlist
Select watchlists to add or remove KTTA